Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Tanaka

Showing results (371-380 of 380) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 380 results.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 17, 2026
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402)Ryo Tanaka, Sang-Woong Lee, Kazumasa Fujitani, et al.
Advances in Clinical Chemistry|January 15, 2023
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markersKoji Kurose, Kanako Sakaeda, Minoru Fukuda, et al.
The Journal of Dermatology|December 10, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025Toshihiro Takai, Takafumi Kadono, Noriki Fujimoto, et al.
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
Journal of Gastrointestinal Cancer|January 20, 2021
The Management of Recurrence of Hepatocellular Carcinoma Occurring Within 6 Months After Hepatic Resection: A Comparative Study Using a Propensity Score Matching AnalysisYoshihiro Inoue, Yusuke Suzuki, Masato Ota, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
JCO Global Oncology|September 12, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective StudyShintaro Saito, Masahito Yasuda, Takeshi Araki, et al.
The American Surgeon|December 7, 2020
Safety and Efficacy of Laparoscopic Liver Resection for Colorectal Liver Metastasis With ObesityYoshihiro Inoue, Masatsugu Ishii, Kensuke Fujii, et al.
Japanese Journal of Clinical Oncology|July 9, 2026
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world studyIbuki Tsuru, Satoru Taguchi, Ryo Tanaka, et al.
Pageof 38

Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 17, 2026
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402)Ryo Tanaka, Sang-Woong Lee, Kazumasa Fujitani, et al.
Advances in Clinical Chemistry|January 15, 2023
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markersKoji Kurose, Kanako Sakaeda, Minoru Fukuda, et al.
The Journal of Dermatology|December 10, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025Toshihiro Takai, Takafumi Kadono, Noriki Fujimoto, et al.
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
Journal of Gastrointestinal Cancer|January 20, 2021
The Management of Recurrence of Hepatocellular Carcinoma Occurring Within 6 Months After Hepatic Resection: A Comparative Study Using a Propensity Score Matching AnalysisYoshihiro Inoue, Yusuke Suzuki, Masato Ota, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
JCO Global Oncology|September 12, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective StudyShintaro Saito, Masahito Yasuda, Takeshi Araki, et al.
The American Surgeon|December 7, 2020
Safety and Efficacy of Laparoscopic Liver Resection for Colorectal Liver Metastasis With ObesityYoshihiro Inoue, Masatsugu Ishii, Kensuke Fujii, et al.
Japanese Journal of Clinical Oncology|July 9, 2026
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world studyIbuki Tsuru, Satoru Taguchi, Ryo Tanaka, et al.
Pageof 38